# Healshape

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/healshape

- Industry: Healthcare
- Headquarters: France
- Website: www.healshape.com
- Total disclosed funding: $3.4M
- Latest round: Seed (Aug 2, 2022)
- Investors on record: 6

## About

Based in Villeurbanne, France, and founded in 2020 by Amelie Thepot, Caroline Durand, Christophe Marquette, Luciano Vidal, and Morgan Dos Santos, Healshape SAS operates as a developer of regenerative medicine that provides bioprosthetic breast volume and 3d bio-printed nipple-areolar complex solutions. In June 2022, Healshape raised EUR 6 million in seed funding co-led by n Demeter Group and Go Capital, with participation from WinEquity, Credit Agricole Reation, and Bpifrance. As of June 2022, Sophie Brac De La Perriere is the CEO of the company.

The company provides Bioprosthesis, a natural prosthesis to regain breast volume through a simple surgery for a long-lasting and aesthetic result; and nipple-areolar complex, a 3D bioprinting solution that facilitates the graft for women who had mastectomy following breast cancer.

Healshape plans to use its proceeds from June 2022 funding to accelerate the development of its bioprosthesis solution for breast reconstruction.

## Funding rounds

- Seed, Aug 2, 2022, $3.4M — GO Capital, Bpifrance, CS Capital, Credit Agricole Creation, Pulsalys, WinEquity

## Investors

- GO Capital — Seed
- Bpifrance — Seed
- CS Capital — Seed
- Credit Agricole Creation (https://capitalatlas.ai/funds/credit-agricole-creation) — Seed
- Pulsalys — Seed
- WinEquity (https://capitalatlas.ai/funds/winequity) — Seed